Measuring ribavirin concentrations during the earliest stages of antiviral therapy for hepatitis C: potential relevance for treatment outcome

L.G. van Vlerken; C.T. de Kanter; G.J. Boland; A.M. van Loon; H. van Soest; G.H. Koek; J.P. Drenth; P.D. Siersema; K.J. van Erpecum; D.M. Burger

Measuring ribavirin concentrations during the earliest stages of antiviral therapy for hepatitis C: potential relevance for treatment outcome

L.G. van Vlerken, C.T. de Kanter, G.J. Boland, A.M. van Loon, H. van Soest, G.H. Koek, J.P. Drenth, P.D. Siersema, K.J. van Erpecum, D.M. Burger

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	546-551
Number of pages	6
Journal	Therapeutic Drug Monitoring
Volume	35
Issue number	4
Publication status	Published - 2013

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/23851908

Cite this

van Vlerken, L. G., de Kanter, C. T., Boland, G. J., van Loon, A. M., van Soest, H., Koek, G. H., Drenth, J. P., Siersema, P. D., van Erpecum, K. J., & Burger, D. M. (2013). Measuring ribavirin concentrations during the earliest stages of antiviral therapy for hepatitis C: potential relevance for treatment outcome. Therapeutic Drug Monitoring, 35(4), 546-551. http://www.ncbi.nlm.nih.gov/pubmed/23851908

@article{57cb4be9c3a4461ca3e45da6066b1d68,

title = "Measuring ribavirin concentrations during the earliest stages of antiviral therapy for hepatitis C: potential relevance for treatment outcome",

author = "{van Vlerken}, L.G. and {de Kanter}, C.T. and G.J. Boland and {van Loon}, A.M. and {van Soest}, H. and G.H. Koek and J.P. Drenth and P.D. Siersema and {van Erpecum}, K.J. and D.M. Burger",

year = "2013",

language = "English",

volume = "35",

pages = "546--551",

journal = "Therapeutic Drug Monitoring",

issn = "0163-4356",

publisher = "Lippincott Williams & Wilkins",

number = "4",

}

van Vlerken, LG, de Kanter, CT, Boland, GJ, van Loon, AM, van Soest, H, Koek, GH, Drenth, JP, Siersema, PD, van Erpecum, KJ & Burger, DM 2013, 'Measuring ribavirin concentrations during the earliest stages of antiviral therapy for hepatitis C: potential relevance for treatment outcome', Therapeutic Drug Monitoring, vol. 35, no. 4, pp. 546-551. <http://www.ncbi.nlm.nih.gov/pubmed/23851908>

TY - JOUR

T1 - Measuring ribavirin concentrations during the earliest stages of antiviral therapy for hepatitis C: potential relevance for treatment outcome

AU - van Vlerken, L.G.

AU - de Kanter, C.T.

AU - Boland, G.J.

AU - van Loon, A.M.

AU - van Soest, H.

AU - Koek, G.H.

AU - Drenth, J.P.

AU - Siersema, P.D.

AU - van Erpecum, K.J.

AU - Burger, D.M.

PY - 2013

Y1 - 2013

M3 - Article

SN - 0163-4356

VL - 35

SP - 546

EP - 551

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

IS - 4

ER -